| Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
|---|
| 03/10/2010 | EP2161239A1 Semiconductor nanocrystals |
| 03/10/2010 | EP2029558B1 Compounds and methods for modulating fxr |
| 03/10/2010 | EP1527041B1 Process for the preparation of primary amines |
| 03/10/2010 | CN101665468A Application of ethyl dihydrazone serving as amination reagent |
| 03/10/2010 | CN101665467A Application of 1-amino-1,2,3-triazole serving as amination reagent |
| 03/10/2010 | CN100593401C Combination of an aromatase inhibitor with a bisphosphonate |
| 03/09/2010 | US7674811 5-lipoxygenase inhibitors |
| 03/09/2010 | US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2329292C A process for the manufacture of sulfonylaminocarbonyl triazolinones and salts thereof under ph controlled conditions |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/04/2010 | WO2010023862A1 5-benzyl-4-azolylmethyl-4-spiro[2.4]heptanol derivatives, methods for producing the same, and agro-horticultural agents and industrial material protecting agents thereof |
| 03/04/2010 | US20100056798 Synthesis of herbicide 5-methoxy-4-methyl-2-[(4-methoxycarbonyl-2-methyl-thien-3-yl)-sulfonylaminocarbonyl]-2,4-dihydro-3H-1,2,4-triazol-3-one or salts aka thiencarbazone-methyl |
| 03/04/2010 | US20100056590 Polymorphic forms of deferasirox (icl670a) |
| 03/04/2010 | US20100056526 3-(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's diseas |
| 03/04/2010 | US20100056465 Compounds, compositions and methods of using same for modulating uric acid levels |
| 03/04/2010 | US20100056464 Compounds, compositions and methods of using same for modulating uric acid levels |
| 03/04/2010 | US20100056426 Use of iron chelator for the treatment of myocardial infarction |
| 03/04/2010 | US20100055056 Agent for improving permeation of a drug into a nail and an external treating agent containing the same |
| 03/04/2010 | CA2726714A1 5-benzyl-4-azolylmethyl-4-spiro[2.4]heptanol derivatives, methods for producing the same, and agro-horticultural agents and industrial material protecting agents thereof |
| 03/03/2010 | EP1893020B1 Derivatives of a 1-phenyltriazole as antiparasitic agents |
| 03/02/2010 | US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors |
| 02/25/2010 | WO2010021693A2 Mif modulators |
| 02/25/2010 | WO2009110985A3 Amide compounds, compositions and uses thereof |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | DE102006053593B4 Verfahren zur Herstellung von Letrozol Process for the preparation of letrozole |
| 02/25/2010 | CA2733554A1 Mif modulators |
| 02/24/2010 | EP2155699A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| 02/24/2010 | EP2155698A1 Novel thermodynamically stable polymorphic form-l of letrozole |
| 02/24/2010 | EP1542678B1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS |
| 02/24/2010 | CN101657433A Non-nucleoside reverse transcriptase inhibitors |
| 02/23/2010 | US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 02/23/2010 | US7666891 Succinic acid mono-{3-[3-(3-cyano-5-difluoromethyl-phenoxy)-4-ethyl-2-fluoro-benzyl]-4-methyl-5-oxo-4,5-dihydro-[1,2,4]triazol-1-ylmethyl}ester; treating diseases mediated by human immunodeficiency virus inhibit HIV. |
| 02/23/2010 | US7666890 Synthesis and herbicidal activity of 1- (2-substituted benzo[d]thiazol-5-yl)-1H-1,2,4-triazol-5(4H)- one derivatives |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/18/2010 | WO2010019101A1 A crystalline form of 4- (5-{ (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } - 4 -methyl- 4h- 1, 2,4- triazol-3-yl) pyridine |
| 02/18/2010 | WO2010019100A1 A new crystalline form of 4- (5- { (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4h-l, 2, 4- triazol-3-yl) pyridine |
| 02/18/2010 | WO2010017902A1 Insecticidal 4-phenyl-1h-pyrazoles |
| 02/18/2010 | US20100041655 Triazole derivative |
| 02/18/2010 | US20100041632 Uses of the carboxy-amido-triazole compounds and salts thereof |
| 02/18/2010 | CA2733958A1 Insecticidal 4-phenyl-1h-pyrazoles |
| 02/18/2010 | CA2733922A1 A crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/18/2010 | CA2733920A1 A new crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | EP2152271A1 Piperidine/piperazine derivatives |
| 02/16/2010 | US7662813 Triazole compounds that modulate HSP90 activity |
| 02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
| 02/16/2010 | US7662750 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/11/2010 | WO2010017545A2 Triazole compounds that modulate hsp90 activity |
| 02/11/2010 | WO2010017479A1 Triazole compounds that modulate hsp90 activity |
| 02/11/2010 | WO2010015583A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | WO2010015212A1 COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ, AND PREPARATION METHOD AND USE THEREOF |
| 02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 02/11/2010 | CA2733499A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | CN101643451A Peroxisome proliferator-activated receptor subtype delta agonist compound and preparation method thereof |
| 02/10/2010 | CN100588650C Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659270 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/09/2010 | CA2614926C Crystal modification c of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | US20100029952 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems |
| 02/04/2010 | US20100029726 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 02/02/2010 | US7655806 crystallilzing anastrozole base, from an aqueous-based solvent containing water and a water soluble solvent selected from dimethyl formamide, dimethyl acetamide, c1-c4 alcohol, and dilute HCl, that contains anastrozol dissolved therein; pharmaceutically acceptable grade of purity |
| 02/02/2010 | US7655805 2-(2-hydroxy-5-methylphenyl) benzotriazole, triethylamine in presence of N,N-dimethylaniline solvent to make a solution, adding 3-chloro-2-alkyl propylene, exchanging air in the reaction vessel for N2, heating to allow a Claisen rearrangement to form 1-methallyl-2-(2-hydroxy-5-methylphenyl) benzotriazole |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 01/28/2010 | WO2010011821A2 Dual-acting antihypertensive agents |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | US20100022599 imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents |
| 01/28/2010 | US20100022542 Compounds exhibiting thrombopoietin receptor agonism |
| 01/28/2010 | US20100022540 Triazole derivatives ii |
| 01/28/2010 | US20100022513 Organic compounds |
| 01/27/2010 | EP2146991A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
| 01/26/2010 | US7652044 P-38 inhibitors |
| 01/26/2010 | US7652043 Inhibiting aberrant growth states in cells having Wnt receptors; carcinoma |
| 01/26/2010 | US7651577 Thermally stable compositions including 2,4,8,10-tetranitro-5H-pyrido[3′,2′:4,5][1,2,3]triazolo[1,2-a]benzotriazol-6-ium, inner salt |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | US20100012889 Uv-absorbers for ophthalmic lens materials |
| 01/21/2010 | CA2731097A1 Organic compounds |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/20/2010 | EP2144507A1 Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques |
| 01/20/2010 | EP1828148B1 Triazole substituted aminobenzophenone compounds |
| 01/20/2010 | EP1663211B1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/19/2010 | US7649003 Substituted triazole derivatives as oxytocin antagonists |
| 01/19/2010 | CA2143135C Process for sulfinylating heterocyclic compounds |
| 01/14/2010 | WO2010004517A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | US20100010054 Therapeutic agent for amyotrophic lateral sclerosis |